In the Wake of Cannabis Export Approval, Medical Cannabis Experts from Science & Business to Gather at CannaTech
Tel Aviv 2019
Tel Aviv, Israel, the Global Capital of Cannabis R&D
March 14, 2019 (Investorideas.com Newswire) Tel Aviv, Israel, March 14, 2019... The world's leading international medical cannabis experts from around the world will gather at Israel's famed CannaTech Summit March 31- April 2, 2019 in Tel Aviv, the global capital of medical cannabis. The event will take place at Trask & Reading 3.
Over 1,000 participants from every continent will come together in Tel Aviv to learn about the latest scientific and business developments in the field as innovative Israeli researchers and scientists, high tech experts and Start-Up Nation entrepreneurs display and share their knowledge with their international colleagues at the best known international gathering of its kind.
Economists foresee the potential overall market worth of cannabis related goods and products in the tens of billions of dollars in the next decade as demand is surging globally and more countries throughout the world legalize the use of the plant. Israel is now only one of 3 nations in the world with approval to export cannabis.
Saul Kaye, Founder and CEO of CannaTech and iCAN Israel-Cannabis said: "Since the Israeli government recently allowed medical cannabis export, interest in the nation's unsurpassed cannabis ecosystem has dramatically increased making CannaTech Tel Aviv 2019, literally, the most important cannabis meeting place in the world. Israel is at the forefront of a new global industry and together, with partners from around the world, we will help tens of millions of patients in need and I could not be prouder to showcase the advances we have made, here, in beautiful Tel Aviv."
MARCH 31: SCIENCE AND BUSINESS SYMPOSIUM
A full day in-depth informational sessions highlighting the brightest minds in medical cannabis:
- Cannabis plant science and medical research
- Cannabis business, industry and finance
APRIL 1-2: CANNATECH TEL AVIV 2019
The two-day conference will cover diverse topics from all sectors of the medical cannabis ecosystem including:
- Latest regulatory and compliance standards
- Next wave of targeted cannabis-based therapies and devices
- Novel cultivation and delivery systems to improve the quality and efficacy of cannabis medicine
"The Deal Room" will be available to connect qualified investors with high market potential companies.
For further information about media coverage, interviewing CannaTech organizers and speakers or for press registration contact Laura Kam, firstname.lastname@example.org; +972-54-806-8613.
About iCAN: Israel-Cannabis
iCAN: Israel-Cannabis is building the Global Cannabis Ecosystem. iCAN is committed to accelerate Israel's Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, and around the world including London, Sydney, Hong Kong, Panama and soon Cape Town in 2019.
CannaTech is the only Medical Cannabis event of its kind with a global focus that offers senior industry leaders, medical and scientific experts, and new ventures the platform to come together, drive innovation, form partnerships and promote knowledge exchange.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com